microRNA-612 suppresses the malignant development of non-small-cell lung cancer by directly targeting bromodomain-containing protein 4.

Kang, Xiaowen; Kong, Fanwu; Wu, Shijie; Liu, Qiushuang; Yang, Chengcheng; Wu, Xiaomei; Zhang, Wei.

Afiliação

Kang X; Department of Respiration, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, People's Republic of China.
Kong F; Department of Nephrology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, People's Republic of China.
Wu S; Department of Respiration, General Hospital of Daqing Oil Field, Daqing, Heilongjiang 163000, People's Republic of China.
Liu Q; Department of Pharmacy, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, People's Republic of China.
Yang C; Department of Respiration, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, People's Republic of China.
Wu X; Department of Respiration, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, People's Republic of China.
Zhang W; Department of Respiration, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150000, People's Republic of China.

Onco Targets Ther ; 12: 4167-4179, 2019.

Article em En | MEDLINE | ID: mdl-31213835